MyMD Pharmaceuticals Price on March 1, 2023

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
If you're considering investing in MyMD Stock, it is important to understand the factors that can impact its price. As of today, the current price of MyMD Pharmaceuticals stands at 1.82, as last reported on the 26th of December, with the highest price reaching 1.89 and the lowest price hitting 1.82 during the day. We have found twenty-three technical indicators for MyMD Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify MyMD Pharmaceuticals' risk adjusted performance of (0.11), and Mean Deviation of 3.6 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
MyMD Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
MYMD
Based on monthly moving average MyMD Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MyMD Pharmaceuticals by adding MyMD Pharmaceuticals to a well-diversified portfolio.

MyMD Pharmaceuticals Valuation on March 1, 2023

It is possible to determine the worth of MyMD Pharmaceuticals on a given historical date. On March 1, 2023 MyMD was worth 57.3 at the beginning of the trading date compared to the closed value of 53.4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MyMD Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find MyMD Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MyMD Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MyMD Pharmaceuticals' related companies.
 Open High Low Close Volume
  56.40    58.50    55.50    57.30    7,460  
03/01/2023
  57.30    58.50    53.04    53.40    8,226  
  53.70    57.60    53.70    56.40    10,688  
Backtest MyMD Pharmaceuticals  |  MyMD Pharmaceuticals History  |  MyMD Pharmaceuticals Valuation   PreviousNext  
Open Value
57.3
53.4
Closing Value
57.30
Upside

MyMD Pharmaceuticals Trading Date Momentum on March 1, 2023

On March 02 2023 MyMD Pharmaceuticals was traded for  56.40  at the closing time. The top price for the day was 57.60  and the lowest listed price was  53.70 . The trading volume for the day was 10.7 K. The trading history from March 2, 2023 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 5.62% . The trading delta at closing time against the current closing price is 19.94% .

MyMD Pharmaceuticals Fundamentals Correlations and Trends

By evaluating MyMD Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MyMD Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MyMD financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About MyMD Pharmaceuticals Stock history

MyMD Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MyMD is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MyMD Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MyMD Pharmaceuticals stock prices may prove useful in developing a viable investing in MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company was founded in 2014 and is headquartered in Baltimore, Maryland. Mymd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.

MyMD Pharmaceuticals Stock Technical Analysis

MyMD Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of MyMD Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of MyMD Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

MyMD Pharmaceuticals Period Price Range

Low
December 26, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

MyMD Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

MyMD Pharmaceuticals December 26, 2024 Market Strength

Market strength indicators help investors to evaluate how MyMD Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MyMD Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying MyMD Pharmaceuticals stock market strength indicators, traders can identify MyMD Pharmaceuticals entry and exit signals to maximize returns

MyMD Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for MyMD Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of MyMD Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MyMD to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges